Form 4: Opus Genetics Executive Ashwath Jayagopal Reports Stock Disposal

Ashwath Jayagopal, Chief Scientific & Development Officer of Opus Genetics, disposed of 5,193 shares of common stock to cover tax obligations.

Summary

• On February 13, 2025, Ashwath Jayagopal, the Chief Scientific & Development Officer of Opus Genetics, disposed of 5,193 shares of common stock.
• The transaction was executed at a price of $1.15 per share.
• Following the transaction, Jayagopal directly owns 73,307 shares of Opus Genetics.
• The transaction was reported on February 18, 2025.

Sentiment

Score: 5

Explanation: The sentiment is neutral as it reports a standard transaction. The disposal of shares by an officer doesn't necessarily indicate a positive or negative outlook for the company.

Industry Context

Form 4 filings are standard disclosures required by the SEC when corporate insiders (officers, directors, or any individuals owning more than 10% of a company's shares) buy or sell their company's stock. These filings provide transparency into insider transactions, allowing investors to see if those with inside knowledge of a company are increasing or decreasing their positions.

Stakeholder Impact

• The transaction may have a minor impact on shareholders as it reflects an insider's decision to sell shares, although the amount is relatively small.

Key Dates